Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)

Authors

Jun Yin, Mayo Clinic - Rochester, MN
Betsy LaPlant, Mayo Clinic - Rochester, MN
Geoffrey L. Uy, Washington University School of Medicine in St. Louis
Guido Marcucci, City of Hope - Duarte, CA
William Blum, Emory University
Richard A. Larson, University of Chicago
Richard M. Stone, Dana-Farber/ Partners CancerCare
Sumithra J. Mandrekar, Mayo Clinic - Rochester, MN

Journal

Blood Advances

Publication Date

2019

Volume

3

Issue

11

Inclusive Pages

1714-1721

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2018026112

Rights and Permissions

Yin, J., LaPlant, B., Uy, G. L., Marcucci, G., Blum, W., Larson, R. A., Stone, R. M., & Mandrekar, S. J. (2019). Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614). Blood Advances, 3(11), 1714-1721. https://doi.org/10.1182/bloodadvances.2018026112.

Recommended Citation

Yin, Jun; LaPlant, Betsy; Uy, Geoffrey L.; Marcucci, Guido; Blum, William; Larson, Richard A.; Stone, Richard M.; and Mandrekar, Sumithra J., "Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)." Blood Advances. 3, 11. 1714-1721. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/7920